Human rights frameworks afford everyone the right to health and the right to enjoy the benefits of scientific progress and its applications. Both come together to create state obligations to ensure access to medicines and other health technologies. Though the impact of patents on access to high-quality, affordable medicines and health technologies has been well described, there has been little attention to the impact of trade secrecy law in this context. In this paper, we describe how trade secrecy protection comes into conflict with access to medicines-for example, by preventing researchers from accessing clinical trial data, undermining the scale-up of manufacturing in pandemics, and deterring whistleblowers from reporting industry misconduct. The paper proposes measures to diminish the conflict between trade secrecy and health that are consistent with international law and will advance health without undermining innovation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233014 | PMC |
PLoS One
January 2025
Business School, Huaqiao University, Quanzhou, Fujian, China.
Global climate change has become one of the most large-scale, widespread, and far-reaching challenges facing mankind. Against this background, China has proposed a "dual-carbon" target in 2020, which greatly demonstrates China's determination and commitment to carbon emission reduction, and the burden of realizing the "dual-carbon" target is mainly borne by heavy polluters. The burden of achieving the "dual-carbon" goal is mainly borne by the heavily polluting firms.
View Article and Find Full Text PDFCureus
December 2024
Department of Emergency and Intensive Care Medicine, Hospital of the University of Occupational and Environmental Health, Fukuoka, JPN.
Objectives The objective of this study was to evaluate the occupational radiation exposure of healthcare workers during positron emission tomography (PET)/CT examinations, focusing on patient positioning and assessing the effectiveness of different radiation protection measures. Methods Thirteen medical workers (physicians, radiological technologists, and nurses) performed PET/CT examinations on 86 patients at a major Japanese hospital from June to August 2019. Occupational doses were measured using a real-time semiconductor dosimeter: RaySafe i2 (Unfors RaySafe, Billdal, Sweden), recording the 1 cm dose equivalent (Hp(10)).
View Article and Find Full Text PDFSci Rep
November 2024
McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, 77030, USA.
For sharing privacy-sensitive data, de-identification is commonly regarded as adequate for safeguarding privacy. Synthetic data is also being considered as a privacy-preserving alternative. Recent successes with numerical and tabular data generative models and the breakthroughs in large generative language models raise the question of whether synthetically generated clinical notes could be a viable alternative to real notes for research purposes.
View Article and Find Full Text PDFBMC Med Ethics
November 2024
Institute of Humanities in Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Background: The COVID-19 pandemic posed many unprecedented challenges to health care systems and public health efforts worldwide. Policy making and science were deeply intertwined, in particular with regard to the justification of health policy measures. In this context, ethical considerations were often at the core of decision-making trade-offs.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!